locacorten-vioform ear drops
amdipharm mercury australia pty ltd - flumetasone pivalate, quantity: 0.2 mg/ml; clioquinol, quantity: 10 mg/ml - ear drops - excipient ingredients: macrogol 300 - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. new indications were approved as specified in the letter of 29 june 1992 from dr alex proudfoot. indicated for the treatment of eczema of the external auditory meatus in which secondary infection with micro-organisms sensitive to clioquinol has occurred. otitis externa. otomycosis.
locacorten-vioform
flumethasone pivalate; clioquinol -
locacorten-vioform
aft pharmaceuticals ltd - clioquinol 1%{relative}; ; flumetasone pivalate 0.02%{relative} - ear drops - active: clioquinol 1%{relative} flumetasone pivalate 0.02%{relative} excipient: macrogol 300 - eczema of the external auditory meatus in which secondary infection with microorganisms sensitive to clioquinol has occurred. · otitis externa · otomycosis.
locacorten vioform cream
paladin labs inc. - clioquinol; flumethasone pivalate - cream - 3%; 0.02% - clioquinol 3%; flumethasone pivalate 0.02% - anti-inflammatory agents
locacorten vioform (0.2mg/10mg)/ml ear drops
locacorten-vioform cream
novartis - clioquinol, flumetasone pivalate - cream - 0.02 , 3 %
locacorten-vioform cream
amdipharma - clioquinol, flumetasone pivalate - cream - 0.02 , 3 %
locacorten-vioform oint. ointment
novartis - clioquinol, flumetasone pivalate - ointment - 0.02 , 3 %
locacorten-vioform oint. ointment
amdipharma - clioquinol, flumetasone pivalate - ointment - 0.02 , 3 %
locacorten tar ointment
novartis pharma-switzerland - topical ointment